Nello Mainolfi insider trades

Open-market stock purchases and sales by Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc, from SEC Form 4 filings since Aug 20, 2020.

Recent trades

DateStockTradeValue
Apr 29, 2026KYMR Kymera Therapeutics, IncSold$1.4M
Apr 29, 2026KYMR Kymera Therapeutics, IncSold$985K
Apr 29, 2026KYMR Kymera Therapeutics, IncSold$77.2K
Apr 29, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 2, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Feb 25, 2026KYMR Kymera Therapeutics, IncSold$139K
Feb 25, 2026KYMR Kymera Therapeutics, IncSold$748
Feb 25, 2026KYMR Kymera Therapeutics, IncSold$1.8M
Feb 25, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Feb 25, 2026KYMR Kymera Therapeutics, IncSold$491K
Feb 25, 2026KYMR Kymera Therapeutics, IncSold$302K
Jan 5, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 31, 2025KYMR Kymera Therapeutics, IncSold$1.9M
Dec 31, 2025KYMR Kymera Therapeutics, IncSold$472K
Dec 31, 2025KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 17, 2025KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 8, 2025KYMR Kymera Therapeutics, IncSold$8.9M
Dec 8, 2025KYMR Kymera Therapeutics, IncBought (not open market)—
Oct 29, 2025KYMR Kymera Therapeutics, IncSold$111K
Oct 29, 2025KYMR Kymera Therapeutics, IncSold$1.5M
Oct 29, 2025KYMR Kymera Therapeutics, IncSold$223K
Oct 29, 2025KYMR Kymera Therapeutics, IncBought (not open market)—

Companies traded

  • KYMR Kymera Therapeutics, Inc: 66 sales, last Apr 29, 2026

Get free alerts when Nello Mainolfi files a new trade →